| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |